HPGC Renmintongtai Pharmaceutical (SHSE:600829) EV-to-FCF : 37.99 (As of Apr. 16, 2025)

HPGC Renmintongtai Pharmaceutical EV-to-FCF Chart

HPGC Renmintongtai Pharmaceutical Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF		Get a 7-Day Free Trial					-197.13	-18.03	12.58	13.70	38.64

HPGC Renmintongtai Pharmaceutical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-FCF	Get a 7-Day Free Trial															13.70	313.80	-20.56	-42.39	38.64

Competitive Comparison of HPGC Renmintongtai Pharmaceutical's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HPGC Renmintongtai Pharmaceutical's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's EV-to-FCF falls into.

HPGC Renmintongtai Pharmaceutical EV-to-FCF Calculation

HPGC Renmintongtai Pharmaceutical's EV-to-FCF for today is calculated as:

HPGC Renmintongtai Pharmaceutical's current Enterprise Value is ¥4,080 Mil.
HPGC Renmintongtai Pharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥107 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HPGC Renmintongtai Pharmaceutical  (SHSE:600829) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

HPGC Renmintongtai Pharmaceutical's PE Ratio (TTM) for today is calculated as:

HPGC Renmintongtai Pharmaceutical's share price for today is ¥7.19.
HPGC Renmintongtai Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.368.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

HPGC Renmintongtai Pharmaceutical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical Business Description